Proteologics' Series A Round

Proteologics raised a round of funding on October 16, 2001.

PROTEOLOGICS develops a class of drugs for viral and other ubiquitin-mediated diseases utilizing technology and knowledge of the ubiquitin system.…

Articles about Proteologics' Series A Round: